Quanterix

📍 Billerica, United States🗓 Founded 2007👥 351 employees💰 Last funded Jan 2015
Biotechnology Research🌐 quanterix.com
Website LinkedIn
Quanterix is a company that is digitizing biomarker analysis with the goal of advancing the science of precision health. The company’s ultra-sensitive detection solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the role of biomarkers in the continuum of health to disease. Quanterix’ technology is designed to enable much earlier disease detection, better prognosis and precise treatment methods to improve the quality of life and longevity of the population for generations to come. The technology is currently being used for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease. The company was established in 2007 and is located in Billerica, Massachusetts.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2007
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Quanterix?
Quanterix has 1 investors on record on gritt.io and 1 late-stage investors.
When did Quanterix last raise funding?
The most recent investment in Quanterix recorded on gritt.io was in January 2015.
When was Quanterix founded?
Quanterix was founded in 2007.
What industry is Quanterix in?
Quanterix operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Quanterix based?
Quanterix is headquartered in Billerica, United States.